Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients
Status:
Completed
Trial end date:
2015-08-20
Target enrollment:
Participant gender:
Summary
The purpose of this study was to investigate if Tacrolimus Hexal® has similar pharmacokinetic
properties compared to Prograf® in de novo renal transplant patients and whether the
comparable exposure resulted in similar renal function.